Gil joined InterWest's healthcare team in 1996 and leads the firm's medical device and healthcare IT franchises. He invests in a broad array of healthcare opportunities, with a special interest in ophthalmology, robotics, and physician-centric mobile applications.
He is a board member of Avedro, Benvenue, Doximity, Glaukos (GKOS), Gobiquity, Restoration Robotics, and ReVision Optics.
Gil has led InterWest's medical device team since 1999 and pioneered InterWest's ophthalmology franchise. He was an early investor in IntraLase, LenSx and Glaukos, category-creating ophthalmic device companies that became standard-of-care for eye surgery around the world. He is also a founder and co-chairman of the Ophthalmology Innovation Summit, the world's largest ophthalmology business conference with over 1000 annual attendees.
Gil is also a successful healthcare IT investor, building this important franchise for InterWest over the last fifteen years through multiple companies. He led the Series A of Epocrates, the industry-leading first mobile application for physicians, serving on the board through its 2011 IPO, and was the founding institutional investor in Doximity, helping to build it into the leading physician social network engaging over 50% of U.S. physicians.
Gil has a B.A. from Harvard University. He received an M.D. from the University of Pennsylvania and an M.B.A. from Stanford University. He completed an ophthalmology residency at Wills Eye Institute and retina fellowship at Massachusetts Eye and Ear Infirmary as a Heed Foundation Fellow. He also serves as a National Trustee for the Foundation Fighting Blindness.
Representative Prior Investments
Epocrates (NASDAQ: EPOC; acquired by Athenahealth in 2013), INC Research (acquired by Avista Capital Partners in 2010), Inspire Pharmaceuticals (IPO 2000, ISPH), IntraLase (IPO 2004, ILSE), LenSx Lasers (acquired by Alcon in 2010), Spinal Dynamics (acquired by Medtronic in 2002), Spiration (acquired by Olympus Medical Systems in 2010)